Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron gains after completion of stake acquisition in Ateria Health

** Shares of Australia's Immuron Ltd  IMC.AX  rise as much
as 6.5% to A$0.082 - set to mark their best day since Nov. 7, if
gains hold
    ** Biopharma co announces completion of strategic investment
in UK-based Ateria Health Ltd
    ** Says completed settlement of upfront cash investment of
A$2.6 mln ($1.76 mln) for a 17.5% stake in issued share capital
of Ateria
    ** Says deal for distribution of irritable bowel syndrome
treatment product JUVIA in Australian and North American
markets, among others
    ** Stock hits highest level since Nov. 8  
    ** IMC had fallen 23% this year, as of last close
($1 = 1.4799 Australian dollars)
 (Reporting by Nausheen Thusoo)
 ((Nausheen.Thusoo@thomsonreuters.com;))

Recent news on Immuron

See all news